Direct vitamin k antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation

Table 4 Average cost according to TTR, type of cost (in Euros), and percentages

	Total	Treatment	INR control	Medical visits	Related admissions	Concomitanmedication
TTR < 49	553.01	20.94	58.13	356.62	10.88	106.44
TTR ≥50	376.85	17.19	45.17	283.93	2.92	27.65
Total	392.90	17.53	46.35	290.55	3.64	34.83
Difference (Dif)	176.16	3.75	12.96	72.69	7.96	78.79
% difference relative to TC	44.84%	21.39%	27.96%	25.02%	218.68%	226.21%

Source: Compiled by the authors. Baseline: Patients included in the sample for a minimum of five months and one day (n = 944).

ISSN: 1472-6963